tirzepatide nome commerciale China Clears Eli Lilly's Weight Loss Drug Tirzepatide, Only For Diabetes Tirzepatide | DirectMeds

The company also states that 83% of members sustain results for one year and that members have collectively lost 1.4 million pounds

Published online July 13, 2025

Nowak C, Hetty S, Salihovic S, Castillejo-Lopez C, Ganna A, Cook NL, et al

Quickobook Call to Action If youre considering GLP-1 therapy for diabetes, obesity, or inflammation control , talk to an expert

What does off-label mean

Large-scale cardiovascular outcome trials have demonstrated that certain GLP-1 agonists, including liraglutide, semaglutide, and dulaglutide, reduce the risk of major adverse cardiovascular events (MACE) such as myocardial infarction, stroke, and cardiovascular death in patients with type 2 diabetes and established cardiovascular disease or multiple risk factors